1,833
Views
55
CrossRef citations to date
0
Altmetric
Editorial

Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy

, &
Pages 135-139 | Published online: 17 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michele Mussap, Cristina Loddo, Claudia Fanni & Vassilios Fanos. (2020) Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics. Expert Review of Clinical Pharmacology 13:2, pages 115-134.
Read now

Articles from other publishers (54)

Minhao Zeng, Xiaoxu Wang, Yangyuan Qiu, Xiaojing Sun, Hongyu Qiu, Xiaoxiao Ma, Qingbo Lv, Junfeng Gao, Chunren Wang & Qiaocheng Chang. (2023) Metabolomic and systematic biochemical analysis of sheep infected with Fasciola hepatica. Veterinary Parasitology 313, pages 109852.
Crossref
Isha Gupta, Sonia Gandhi & Sameer Sapra. 2023. Smart Nanomaterials Targeting Pathological Hypoxia. Smart Nanomaterials Targeting Pathological Hypoxia 383 398 .
Vivi BafitiTheodora Katsila. (2022) Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean. OMICS: A Journal of Integrative Biology.
Crossref
Hong Zou, Caihua Huang, Lin Zhou, Ruohan Lu, Yimin Zhang & Donghai Lin. (2022) NMR-Based Metabolomic Analysis for the Effects of Trimethylamine N-Oxide Treatment on C2C12 Myoblasts under Oxidative Stress. Biomolecules 12:9, pages 1288.
Crossref
Ping Du, Lihong Liu, Ting Hu & Zhuoling An. (2022) Integrative Analysis of Pharmacokinetic and Metabolomic Profiles for Predicting Metabolic Phenotype and Drug Exposure Caused by Sotorasib in Rats. Frontiers in Oncology 12.
Crossref
Ping Du, Guoyong Wang, Ting Hu, Han Li & Zhuoling An. (2022) Integration Analysis of Pharmacokinetics and Metabolomics to Predict Metabolic Phenotype and Drug Exposure of Remdesivir. Frontiers in Pharmacology 12.
Crossref
Mariano Bizzarri, Andrea Pensotti, Alessandra Cucina, Noemi Monti & Valeria Fedeli. 2022. Personalized Medicine in the Making. Personalized Medicine in the Making 63 86 .
Ping Du, Guo-yong Wang, Rui Zhao, Zhuo-ling An & Li-hong Liu. (2021) Eicosanoid Metabolomic Profile of Remdesivir Treatment in Rat Plasma by High-Performance Liquid Chromatography Mass Spectrometry. Frontiers in Pharmacology 12.
Crossref
Helena T. Hogberg, Rita de Cássia da Silveira E Sá, Andre Kleensang, Mounir Bouhifd, Ozge Cemiloglu Ulker, Lena Smirnova, Mamta Behl, Alexandra Maertens, Liang Zhao & Thomas Hartung. (2020) Organophosphorus flame retardants are developmental neurotoxicants in a rat primary brainsphere in vitro model. Archives of Toxicology 95:1, pages 207-228.
Crossref
Ting Hu, Zhuoling An, Yongkun Sun, Xunqiang Wang, Ping Du, Pengfei Li, Yihebali Chi & Lihong Liu. (2020) Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and Toxicity. Frontiers in Oncology 10.
Crossref
Susanne B Haga. (2020) Individualizing pharmacogenomic test results in the context of the microbiome. Personalized Medicine 17:6, pages 459-468.
Crossref
Joseph F. Pierre, Oguz Akbilgic, Heather Smallwood, Xueyuan Cao, Elizabeth A. Fitzpatrick, Senen Pena, Stephen P. Furmanek, Julio A. Ramirez & Colleen B. Jonsson. (2020) Discovery and predictive modeling of urine microbiome, metabolite and cytokine biomarkers in hospitalized patients with community acquired pneumonia. Scientific Reports 10:1.
Crossref
Sarah Zernia, Nieck Jordy van der Heide, Nicole Stéphanie Galenkamp, Giorgos Gouridis & Giovanni Maglia. (2020) Current Blockades of Proteins inside Nanopores for Real-Time Metabolome Analysis. ACS Nano 14:2, pages 2296-2307.
Crossref
Weihua Huang & Wei Zhang. 2020. Pharmacogenomics in Precision Medicine. Pharmacogenomics in Precision Medicine 181 199 .
Pierre Zalloua, Hanane Kadar, Essa Hariri, Layal Abi Farraj, Francois Brial, Lyamine Hedjazi, Aurelie Le Lay, Alexandre Colleu, Justine Dubus, David Touboul, Fumihiko Matsuda, Mark Lathrop, Jeremy K. Nicholson, Marc-Emmanuel Dumas & Dominique Gauguier. (2019) Untargeted Mass Spectrometry Lipidomics identifies correlation between serum sphingomyelins and plasma cholesterol. Lipids in Health and Disease 18:1.
Crossref
Jeremy R. Everett, Elaine Holmes, Kirill A. Veselkov, John C. Lindon & Jeremy K. Nicholson. (2019) A Unified Conceptual Framework for Metabolic Phenotyping in Diagnosis and Prognosis. Trends in Pharmacological Sciences 40:10, pages 763-773.
Crossref
Inês Laíns, Mari Gantner, Salome Murinello, Jessica A. Lasky-Su, Joan W. Miller, Martin Friedlander & Deeba Husain. (2019) Metabolomics in the study of retinal health and disease. Progress in Retinal and Eye Research 69, pages 57-79.
Crossref
Bing Wang, Huizeng Sun, Xuehui Wu, Linshu Jiang, Le Luo Guan & Jianxin Liu. (2018) Arteriovenous blood metabolomics: An efficient method to determine the key metabolic pathway for milk synthesis in the intra-mammary gland. Scientific Reports 8:1.
Crossref
Feng Lin, Yi Ou, Chuan-Zhong Huang, Sheng-Zhe Lin & Yun-Bin Ye. (2017) Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats. Scientific Reports 7:1.
Crossref
Séverine Trabado, Abdallah Al-Salameh, Vincent Croixmarie, Perrine Masson, Emmanuelle Corruble, Bruno Fève, Romain Colle, Laurent Ripoll, Bernard Walther, Claire Boursier-Neyret, Erwan Werner, Laurent Becquemont & Philippe Chanson. (2017) The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age. PLOS ONE 12:3, pages e0173615.
Crossref
Qiong Wu, Xue-li Lai, Hong-xia Zhao, Zhen-yu Zhu, Zhan-ying Hong, Zhi-yong Guo & Yi-feng Chai. (2017) A metabolomics approach for predicting the response to intravenous iron therapy in peritoneal dialysis patients with anemia. RSC Advances 7:4, pages 1915-1922.
Crossref
Vasudev Kantae, Elke H. J. Krekels, Michiel J. Van Esdonk, Peter Lindenburg, Amy C. Harms, Catherijne A. J. Knibbe, Piet H. Van der Graaf & Thomas Hankemeier. (2016) Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy. Metabolomics 13:1.
Crossref
Ashfaque Hossain, Godfred Menezes, Mohammad Al & Ibraheem Ashankyty. 2016. Food Toxicology. Food Toxicology 491 518 .
Dorsa Varshavi, Dorna Varshavi & Jeremy R Everett. (2016) The role of pharmacometabonomics in predicting drug pharmacokinetics. International Journal of Pharmacokinetics 1:1, pages 5-8.
Crossref
Naomi J Rankin, David Preiss, Paul Welsh & Naveed Sattar. (2016) Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future: Table 1.. International Journal of Epidemiology 45:5, pages 1351-1371.
Crossref
Jeremy R. Everett. (2016) From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine. Frontiers in Pharmacology 7.
Crossref
Richard D. Beger, Warwick Dunn, Michael A. Schmidt, Steven S. Gross, Jennifer A. Kirwan, Marta Cascante, Lorraine Brennan, David S. Wishart, Matej Oresic, Thomas Hankemeier, David I. Broadhurst, Andrew N. Lane, Karsten Suhre, Gabi Kastenmüller, Susan J. Sumner, Ines Thiele, Oliver Fiehn & Rima Kaddurah-Daouk. (2016) Metabolomics enables precision medicine: “A White Paper, Community Perspective”. Metabolomics 12:9.
Crossref
Ali Aboel Dahab, Dhia El-Hag, Gamal M. Moutamed, Sarah Aboel Dahab, Ramadan Abuknesha & Norman W. Smith. (2016) Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics. Cancer Chemotherapy and Pharmacology 78:3, pages 465-489.
Crossref
T Burt & S Nandal. (2016) Pharmacometabolomics in Early‐Phase Clinical Development. Clinical and Translational Science 9:3, pages 128-138.
Crossref
Xiaochen Huang, Shulan Su, Jin-Ao Duan, Xiuxiu Sha, Kavin Yue Zhu, Jianming Guo, Li Yu, Pei Liu, Erxin Shang & Dawei Qian. (2016) Effects and mechanisms of Shaofu-Zhuyu decoction and its major bioactive component for Cold - Stagnation and Blood – Stasis primary dysmenorrhea rats. Journal of Ethnopharmacology 186, pages 234-243.
Crossref
Theodora Katsila, Evangelia Konstantinou, Ioanna Lavda, Harilaos Malakis, Ioanna Papantoni, Lamprini Skondra & George P. Patrinos. (2016) Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease. EBioMedicine 5, pages 40-45.
Crossref
Jeremy R. Everett, John C. Lindon & Jeremy K. Nicholson. 2016. Metabolic Phenotyping in Personalized and Public Healthcare. Metabolic Phenotyping in Personalized and Public Healthcare 137 165 .
Gregor Reid. 2016. The Role of Bacteria in Urology. The Role of Bacteria in Urology 1 6 .
Yipeng Song, Ruifang Zhao, Yili Hu, Fuhua Hao, Ning Li, Guangjun Nie, Huiru Tang & Yulan Wang. (2015) Assessment of the Biological Effects of a Multifunctional Nano-Drug-Carrier and Its Encapsulated Drugs. Journal of Proteome Research 14:12, pages 5193-5201.
Crossref
Qing Huang, Jiye Aa, Huning Jia, Xiaoqing Xin, Chunlei Tao, Linsheng Liu, Bingjie Zou, Qinxin Song, Jian Shi, Bei Cao, Yonghong Yong, Guangji Wang & Guohua Zhou. (2015) A Pharmacometabonomic Approach To Predicting Metabolic Phenotypes and Pharmacokinetic Parameters of Atorvastatin in Healthy Volunteers. Journal of Proteome Research 14:9, pages 3970-3981.
Crossref
Elaine Holmes, Anisha Wijeyesekera, Simon D. Taylor-Robinson & Jeremy K. Nicholson. (2015) The promise of metabolic phenotyping in gastroenterology and hepatology. Nature Reviews Gastroenterology & Hepatology 12:8, pages 458-471.
Crossref
Jeremy R. Everett. 2007. eMagRes. eMagRes 197 208 .
Jeremy R Everett. (2015) Pharmacometabonomics in humans: a new tool for personalized medicine. Pharmacogenomics 16:7, pages 737-754.
Crossref
Warwick B. Dunn, Wanchang Lin, David Broadhurst, Paul Begley, Marie Brown, Eva Zelena, Andrew A. Vaughan, Antony Halsall, Nadine Harding, Joshua D. Knowles, Sue Francis-McIntyre, Andy Tseng, David I. Ellis, Steve O’Hagan, Gill Aarons, Boben Benjamin, Stephen Chew-Graham, Carly Moseley, Paula Potter, Catherine L. Winder, Catherine Potts, Paula Thornton, Catriona McWhirter, Mohammed Zubair, Martin Pan, Alistair Burns, J. Kennedy Cruickshank, Gordon C. Jayson, Nitin Purandare, Frederick C. W. Wu, Joe D. Finn, John N. Haselden, Andrew W. Nicholls, Ian D. Wilson, Royston Goodacre & Douglas B. Kell. (2014) Molecular phenotyping of a UK population: defining the human serum metabolome. Metabolomics 11:1, pages 9-26.
Crossref
Shi-Kai YAN, Run-Hui LIU, Hui-Zi JIN, Xin-Ru LIU, Ji YE, Lei SHAN & Wei-Dong ZHANG. (2015) “Omics” in pharmaceutical research: overview, applications, challenges, and future perspectives. Chinese Journal of Natural Medicines 13:1, pages 3-21.
Crossref
L. Brennan. 2015. Metabolomics as a Tool in Nutrition Research. Metabolomics as a Tool in Nutrition Research 137 144 .
Guoxiang Xie & Wei Jia. 2015. Metabonomics and Gut Microbiota in Nutrition and Disease. Metabonomics and Gut Microbiota in Nutrition and Disease 63 82 .
François-Pierre Martin & Sunil Kochhar. 2015. Metabonomics and Gut Microbiota in Nutrition and Disease. Metabonomics and Gut Microbiota in Nutrition and Disease 1 24 .
Gift Nyamundanda, Isobel Claire Gormley & Lorraine Brennan. (2014) A Dynamic Probabilistic Principal Components Model for the Analysis of Longitudinal Metabolomics Data. Journal of the Royal Statistical Society Series C: Applied Statistics 63:5, pages 763-782.
Crossref
Anthony C. Dona, Beatriz Jiménez, Hartmut Schäfer, Eberhard Humpfer, Manfred Spraul, Matthew R. Lewis, Jake T. M. Pearce, Elaine Holmes, John C. Lindon & Jeremy K. Nicholson. (2014) Precision High-Throughput Proton NMR Spectroscopy of Human Urine, Serum, and Plasma for Large-Scale Metabolic Phenotyping. Analytical Chemistry 86:19, pages 9887-9894.
Crossref
Lynnette Ferguson, Karen Bishop & Nishi Karunsinghe. 2014. Clinical Aspects of Functional Foods and Nutraceuticals. Clinical Aspects of Functional Foods and Nutraceuticals 371 380 .
Sonja B. Nikolic, James E. Sharman, Murray J. Adams & Lindsay M. Edwards. (2014) Metabolomics in hypertension. Journal of Hypertension 32:6, pages 1159-1169.
Crossref
Mounir Bouhifd, Thomas Hartung, Helena T. Hogberg, Andre Kleensang & Liang Zhao. (2013) Review: Toxicometabolomics. Journal of Applied Toxicology 33:12, pages 1365-1383.
Crossref
Jeremy R Everett, Ruey Leng Loo & Francis S Pullen. (2013) Pharmacometabonomics and personalized medicine. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 50:6, pages 523-545.
Crossref
Xiaojiao Zheng, Guoxiang Xie & Wei Jia. (2013) Metabolomic profiling in colorectal cancer: opportunities for personalized medicine. Personalized Medicine 10:7, pages 741-755.
Crossref
Jinchun Sun, Richard D Beger & Laura K Schnackenberg. (2013) Metabolomics as a tool for personalizing medicine: 2012 update. Personalized Medicine 10:2, pages 149-161.
Crossref
Urs A. MeyerUlrich M. ZangerMatthias Schwab. (2013) Omics and Drug Response. Annual Review of Pharmacology and Toxicology 53:1, pages 475-502.
Crossref
Pei Liu, Jinao Duan, Peijuan Wang, Dawei Qian, Jianming Guo, Erxin Shang, Shulan Su, Yuping Tang & Zongxiang Tang. (2013) Biomarkers of primary dysmenorrhea and herbal formula intervention: an exploratory metabonomics study of blood plasma and urine. Mol. BioSyst. 9:1, pages 77-87.
Crossref
Samia Boudah, Alain Paris & Christophe Junot. 2013. Metabolomics Coming of Age with its Technological Diversity. Metabolomics Coming of Age with its Technological Diversity 159 218 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.